ADVERTISEMENT

genetics & genomics, clinical trials

23andMe Partners with Pfizer
Jef Akst | Jan 13, 2015 | 1 min read
The personal genomics company strikes yet another deal to glean biomedically relevant information from its user data.
The Year in Pathogens
Molly Sharlach | Dec 28, 2014 | 4 min read
Ebola, MERS, and enterovirus D68; polio eradication efforts; new regulations on potentially dangerous research
Statins Stimulate Bone Growth?
Kate Yandell | Sep 17, 2014 | 3 min read
The cholesterol-lowering drugs could be used to treat people with two types of dwarfism, a study suggests.
Week in Review: June 16–20
Tracy Vence | Jun 20, 2014 | 2 min read
Early Neanderthal evolution; developing antivirals to combat polio; the mouth and skin microbiomes; insect-inspired, flight-stabilizing sensors
Week in Review: May 5–9
Tracy Vence | May 8, 2014 | 4 min read
Synthetic base pairs replicated in vivo; cardiac stem cells questioned; miniature neurotransmissions and synaptic development; neurogenesis and memory loss; STAP saga continues
Opinion: Overcoming Cancer’s Complexities
Daniel S. Kapp, David Rubenson, and Beverly Mitchell | Apr 11, 2014 | 4 min read
Considering “targeted therapeutics” in the face of intra-patient heterogeneity. 
The Right to Know—or Not
Tracy Vence | Dec 12, 2013 | 2 min read
Consumers, patients, and study participants should be made aware of potential incidental findings, according to a federally-appointed bioethics panel.
Pharmacogenetics Puzzle
Tracy Vence | Nov 20, 2013 | 2 min read
Conflicting clinical trial results leave researchers unsure whether genetic information is useful for determining initial Warfarin dosage.
Virus Versus Bacteria
Edyta Zielinska | Apr 17, 2013 | 1 min read
A newly developed drug, modeled after a bacteria-infecting virus, is less likely to become antibiotic resistant.
Cancer Clinical Trials of Tomorrow
Tomasz M. Beer | Apr 1, 2013 | 4 min read
Advances in genomics and cancer biology will alter the design of human cancer studies.
Making Cancer More Transparent
Mary Beth Aberlin | Apr 1, 2013 | 3 min read
A decade into the age of genomics, science is generating a flood of data that will help in the quest to eradicate the disease.
More Oversight for Omics Tests
N/A | Mar 27, 2012 | 1 min read
A new report outlines ways in which omics-based technologies can be shuttled more safely and effectively from the bench to the clinic.
My DNA, My Results
Cristina Luiggi | Mar 22, 2012 | 1 min read
Are donors of biological material privy to research results that stem from their donation?
Regulating the Humanized
Bob Grant | Jul 25, 2011 | 1 min read
A UK panel puts forth guidelines for research that use experimental animals harboring human cells and tissues.
The ghost of personalized medicine
Bob Grant | Jun 14, 2011 | 4 min read
Drug therapies tailored to the DNA profiles of individual patients could change the face of medicine, but such treatments aren't commonly used in the clinic.
ADVERTISEMENT